A Genetic Screen for Isolating "Lariat" Peptide Inhibitors of Protein Function

Chemistry and Biology

Volumn 16, Issue 11, 2009, Pages 1148-1157

  Barreto, Kris ^a   Bharathikumar, V M ^a   Ricardo, Alonso ^b   DeCoteau, John F ^a   Luo, Yu ^a   Geyer, C Ronald ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

CHEMBIO; PROTEINS

Indexed keywords

BACTERIAL PROTEIN; CYCLOPEPTIDE; LACTONE; LEXA PROTEIN, BACTERIA; PEPTIDE LIBRARY; SERINE PROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; CHEMISTRY; CHROMATIN IMMUNOPRECIPITATION; COMBINATORIAL CHEMISTRY; DNA REPAIR; DRUG ANTAGONISM; GENETICS; METABOLISM; PROTEIN BINDING; REPORTER GENE; SURFACE PLASMON RESONANCE; TRANSCRIPTION INITIATION; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CHROMATIN IMMUNOPRECIPITATION; COMBINATORIAL CHEMISTRY TECHNIQUES; GENES, REPORTER; LACTONES; PEPTIDE LIBRARY; PEPTIDES, CYCLIC; PROTEIN BINDING; SERINE ENDOPEPTIDASES; SOS RESPONSE (GENETICS); SURFACE PLASMON RESONANCE; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

BACTERIA (MICROORGANISMS);

EID: 72049113295     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2009.10.012     Document Type: Article

References (47)

1. Abedi M.R., Caponigro G., and Kamb A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26 (1998) 623-630
2. Brent R., and Ptashne M. Mechanism of action of the lexA gene product. Proc. Natl. Acad. Sci. USA 78 (1981) 4204-4208
3. Butala M., Hodoscek M., Anderluh G., Podlesek Z., and Zgur-Bertok D. Intradomain LexA rotation is a prerequisite for DNA binding specificity. FEBS Lett. 581 (2007) 4816-4820
4. Chattopadhyaya R., and Pal A. Improved model of a LexA repressor dimer bound to recA operator. J. Biomol. Struct. Dyn. 21 (2004) 681-689
5. Cheng L., Naumann T.A., Horswill A.R., Hong S.J., Venters B.J., Tomsho J.W., Benkovic S.J., and Keiler K.C. Discovery of antibacterial cyclic peptides that inhibit the ClpXP protease. Protein Sci. 16 (2007) 1535-1542
6. Cirz R.T., Chin J.K., Andes D.R., de Crécy-Lagard V., Craig W.A., and Romesberg F.E. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol. 3 (2005) e176
7. Cohen B.A., Colas P., and Brent R. An artificial cell-cycle inhibitor isolated from a combinatorial library. Proc. Natl. Acad. Sci. USA 95 (1998) 14272-14277
8. Colas P., Cohen B., Ko Ferrigno P., Silver P.A., and Brent R. Targeted modification and transportation of cellular proteins. Proc. Natl. Acad. Sci. USA 97 (2000) 13720-13725
9. Davidson A.R., and Sauer R.T. Folded proteins occur frequently in libraries of random amino acid sequences. Proc. Natl. Acad. Sci. USA 91 (1994) 2146-2150
10. Finley Jr. R.L., and Brent R. Interaction mating reveals binary and ternary connections between Drosophila cell cycle regulators. Proc. Natl. Acad. Sci. USA 91 (1994) 12980-12984
11. Geyer C.R., and Brent R. Selection of genetic agents from random peptide aptamer expression libraries. Methods Enzymol. 328 (2000) 171-208
12. Golemis E.A., and Brent R. Fused protein domains inhibit DNA binding by LexA. Mol. Cell. Biol. 12 (1992) 3006-3014
13. Groban E.S., Johnson M.B., Banky P., Burnett P.G., Calderon G.L., Dwyer E.C., Fuller S.N., Gebre B., King L.M., Sheren I.N., et al. Binding of the Bacillus subtilis LexA protein to the SOS operator. Nucleic Acids Res. 33 (2005) 6287-6295
14. Grünewald J., and Marahiel M.A. Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides. Microbiol. Mol. Biol. Rev. 70 (2006) 121-146
15. Gyuris J., Golemis E., Chertkov H., and Brent R. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2. Cell 75 (1993) 791-803
16. Hagelin G. Mass spectrometric investigation of Maltacines E1a and E1b-two members of the Maltacine family of peptide antibiotics. Rapid Commun. Mass Spectrom. 19 (2005) 3633-3642
17. Horswill A.R., and Benkovic S.J. Cyclic peptides, a chemical genetics tool for biologists. Cell Cycle 4 (2005) 552-555
18. Horswill A.R., Savinov S.N., and Benkovic S.J. A systematic method for identifying small-molecule modulators of protein-protein interactions. Proc. Natl. Acad. Sci. USA 101 (2004) 15591-15596
19. Kinsella T.M., Ohashi C.T., Harder A.G., Yam G.C., Li W., Peelle B., Pali E.S., Bennett M.K., Molineaux S.M., Anderson D.A., et al. Retrovirally delivered random cyclic Peptide libraries yield inhibitors of interleukin-4 signaling in human B cells. J. Biol. Chem. 277 (2002) 37512-37518
20. Klevenz B., Butz K., and Hoppe-Seyler F. Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding. Cell. Mol. Life Sci. 59 (2002) 1993-1998
21. Kolonin M.G., Zhong J., and Finley R.L. Interaction mating methods in two-hybrid systems. Methods Enzymol. 328 (2000) 26-46
22. Kritzer J.A., Hamamichi S., McCaffery J.M., Santagata S., Naumann T.A., Caldwell K.A., Caldwell G.A., and Lindquist S. Rapid selection of cyclic peptides that reduce alpha-synuclein toxicity in yeast and animal models. Nat. Chem. Biol. 5 (2009) 655-663
23. Lin L.L., and Little J.W. Isolation and characterization of noncleavable (Ind-) mutants of the LexA repressor of Escherichia coli K-12. J. Bacteriol. 170 (1988) 2163-2173
24. Little J.W., and Harper J.E. Identification of the lexA gene product of Escherichia coli K-12. Proc. Natl. Acad. Sci. USA 76 (1979) 6147-6151
25. Little J.W., Mount D.W., and Yanisch-Perron C.R. Purified lexA protein is a repressor of the recA and lexA genes. Proc. Natl. Acad. Sci. USA 78 (1981) 4199-4203
26. Luo Y., Pfuetzner R.A., Mosimann S., Paetzel M., Frey E.A., Cherney M., Kim B., Little J.W., and Strynadka N.C. Crystal structure of LexA: a conformational switch for regulation of self-cleavage. Cell 106 (2001) 585-594
27. Ma H., Kunes S., Schatz P.J., and Botstein D. Plasmid construction by homologous recombination in yeast. Gene 58 (1987) 201-216
28. McLafferty M.A., Kent R.B., Ladner R.C., and Markland W. M13 bacteriophage displaying disulfide-constrained microproteins. Gene 128 (1993) 29-36
29. Miller C., Thomsen L.E., Gaggero C., Mosseri R., Ingmer H., and Cohen S.N. SOS response induction by beta-lactams and bacterial defense against antibiotic lethality. Science 305 (2004) 1629-1631
30. Naumann T.A., Savinov S.N., and Benkovic S.J. Engineering an affinity tag for genetically encoded cyclic peptides. Biotechnol. Bioeng. 92 (2005) 820-830
31. Naumann T.A., Tavassoli A., and Benkovic S.J. Genetic selection of cyclic peptide Dam methyltransferase inhibitors. ChemBioChem 9 (2008) 194-197
32. Nilsson L.O., Louassini M., and Abel-Santos E. Using siclopps for the discovery of novel antimicrobial peptides and their targets. Protein Pept. Lett. 12 (2005) 795-799
33. Raleigh E.A., Elbing K., and Brent R. Selected topics from classical bacterial genetics. Curr. Protoc. Mol. Biol. 1 (2002) Unit 1.4
34. Roland K.L., Smith M.H., Rupley J.A., and Little J.W. In vitro analysis of mutant LexA proteins with an increased rate of specific cleavage. J. Mol. Biol. 228 (1992) 395-408
35. Sassanfar M., and Roberts J.W. Nature of the SOS-inducing signal in Escherichia coli. The involvement of DNA replication. J. Mol. Biol. 212 (1990) 79-96
36. Schiestl R.H., and Gietz R.D. High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet. 16 (1989) 339-346
37. Scott C.P., Abel-Santos E., Wall M., Wahnon D.C., and Benkovic S.J. Production of cyclic peptides and proteins in vivo. Proc. Natl. Acad. Sci. USA 96 (1999) 13638-13643
38. Scott C.P., Abel-Santos E., Jones A.D., and Benkovic S.J. Structural requirements for the biosynthesis of backbone cyclic peptide libraries. Chem. Biol. 8 (2001) 801-815
39. Slilaty S.N., and Little J.W. Lysine-156 and serine-119 are required for LexA repressor cleavage: a possible mechanism. Proc. Natl. Acad. Sci. USA 84 (1987) 3987-3991
40. Tamimi Y., Lines M., Coca-Prados M., and Walter M.A. Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment. Invest. Ophthalmol. Vis. Sci. 45 (2004) 3904-3913
41. Tavassoli A., and Benkovic S.J. Genetically selected cyclic-peptide inhibitors of AICAR transformylase homodimerization. Angew. Chem. Int. Ed. Engl. 44 (2005) 2760-2763
42. Tavassoli A., Lu Q., Gam J., Pan H., Benkovic S.J., and Cohen S.N. Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS Chem. Biol. 3 (2008) 757-764
43. Wade J.T., and Struhl K. Association of RNA polymerase with transcribed regions in Escherichia coli. Proc. Natl. Acad. Sci. USA 101 (2004) 17777-17782
44. Wade J.T., Reppas N.B., Church G.M., and Struhl K. Genomic analysis of LexA binding reveals the permissive nature of the Escherichia coli genome and identifies unconventional target sites. Genes Dev. 19 (2005) 2619-2630
45. Walker G.C. Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli. Microbiol. Rev. 48 (1984) 60-93
46. Woodman R., Yeh J.T., Laurenson S., and Ko Ferrigno P. Design and validation of a neutral protein scaffold for the presentation of peptide aptamers. J. Mol. Biol. 352 (2005) 1118-1133
47. Yasuda T., Morimatsu K., Horii T., Nagata T., and Ohmori H. Inhibition of Escherichia coli RecA coprotease activities by DinI. EMBO J. 17 (1998) 3207-3216